Clinical pharmacokinetics of adefovir in human immunodeficiency virus type 1-infected patients.

The pharmacokinetics and bioavailability of adefovir [9-[2-(phosphonomethoxy)ethyl]adenine] were examined at two dose levels in three phase I/II studies in 28 human immunodeficiency type 1-infected patients. The concentrations of adefovir in serum following the intravenous infusion of 1.0 or 3.0 mg/...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Cundy, K C, Barditch-Crovo, P, Walker, R E, Collier, A C, Ebeling, D, Toole, J, Jaffe, H S
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1995
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC162955/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8585716/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.39.11.2401
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!